TP53 and neoplasm: These mechanisms include the binding of TP53, increasing TP53 stability and transcriptional activity, and the interaction with the APC/C (anaphase-promoting complex/cyclosome), enhancing the tumor-suppressive activity of the APC-CDH1 complex [6,7].